RELATING TO INSURANCE -- BENEFIT DETERMINATION AND UTILIZATION, REVIEW ACT
Impact
The implications of H7187 are significant, particularly for individuals receiving treatment for alcohol or opioid use disorders. It explicitly forbids any prospective or concurrent review by insurers for specific medications used in these treatments, including Methadone, Buprenorphine, or Naltrexone. This legislative measure seeks to simplify access to crucial medications for addiction treatment, thus promoting better health outcomes for patients and potentially reducing the burden on healthcare systems faced with opioid-related issues.
Summary
House Bill H7187 aims to amend the existing Benefit Determination and Utilization Review Act by prohibiting healthcare insurers from conducting retrospective utilization reviews for prescription medications if prior approval has been obtained. This is intended to protect patients from coverage denials after they have received necessary medical treatments, ensuring that care is not jeopardized due to administrative processes unless issues of fraud or substantial misrepresentation exist. The bill's effective date is set to commence on January 1, 2027, for relevant health benefit plans.
Contention
While supporters advocate for the bill as a necessary step for patient rights and public health, concerns may arise regarding the administrative effectiveness and financial impact on insurers. Critics may argue that the lack of utilization review could lead to inappropriate prescribing practices if not monitored, ultimately affecting healthcare costs and outcomes. Balancing patient access to necessary treatments while ensuring responsible prescribing is likely to be a significant point of contention as the bill progresses through the legislative process.
Requires health insurance plans to cover services provided by licensed certified professional midwives. Insurers must report utilization and cost data annually. Certain limited benefit policies are exempt.
Creates the Rhode Island Individual Market Affordability Act of 2024 to help reduce out-of-pocket costs for low- and moderate-income consumers enrolled in the health insurance coverage through the Rhode Island health benefits exchange.
Creates the Rhode Island Individual Market Affordability Act of 2024 to help reduce out-of-pocket costs for low- and moderate-income consumers enrolled in the health insurance coverage through the Rhode Island health benefits exchange.
Eliminates the "until June 30, 2025" sunset on the increase in the total amount of earnings a partial-unemployment insurance claimant can receive before being entirely disqualified for unemployment insurance benefits.
Eliminates the "until June 30, 2025" sunset on the increase in the total amount of earnings a partial-unemployment insurance claimant can receive before being entirely disqualified for unemployment insurance benefits.
Requires DCYF to establish segregated savings account for foster care child receiving SS, SSI, veterans benefits or railroad retirement benefits to manage the accounts and keep child eligible for future benefits.